Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ROK vs GSK✓SelectedUSD · GSKROK vs GSK performance historyLatest closeAs of-5.53%11/20
Stock and ETF performance explorer

ROK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+13.3%
GSK return
+40.7%
Excess return
-27.3%
Maximum drawdown
-45.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.5%-0.1%-5.4%-5.5%
7D-9.7%-5.3%-4.4%-8.9%
30D-17.2%-3.7%-13.5%-16.7%
3M-15.8%-7.3%-8.6%-14.8%
6M-16.5%-4.2%-12.2%-16.2%
YTD-5.7%+0.9%-6.6%-6.7%
1Y-0.5%+7.3%-7.8%-2.8%
3Y+40.1%+52.7%-12.7%+24.0%
All+13.3%+40.7%-27.3%-5.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling